IL58906A - Agent for the therapy of immunocomplex diseases - Google Patents

Agent for the therapy of immunocomplex diseases

Info

Publication number
IL58906A
IL58906A IL58906A IL5890679A IL58906A IL 58906 A IL58906 A IL 58906A IL 58906 A IL58906 A IL 58906A IL 5890679 A IL5890679 A IL 5890679A IL 58906 A IL58906 A IL 58906A
Authority
IL
Israel
Prior art keywords
therapy
agent
immunocomplex
diseases
immunocomplex diseases
Prior art date
Application number
IL58906A
Other versions
IL58906A0 (en
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of IL58906A0 publication Critical patent/IL58906A0/en
Publication of IL58906A publication Critical patent/IL58906A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

What is disclosed is a method for the therapy of immunocomplex diseases with an agent which contains Fc-reagents that react with the Fc-part of the antibody contained in the immunocomplex, but which themselves do not posses an immunologically active Fc-part or an Fc-part capable of being activated.
IL58906A 1978-12-11 1979-12-10 Agent for the therapy of immunocomplex diseases IL58906A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782853453 DE2853453A1 (en) 1978-12-11 1978-12-11 AGENT FOR THE THERAPY OF IMMUNE COMPLEX DISEASES

Publications (2)

Publication Number Publication Date
IL58906A0 IL58906A0 (en) 1980-03-31
IL58906A true IL58906A (en) 1982-11-30

Family

ID=6056859

Family Applications (1)

Application Number Title Priority Date Filing Date
IL58906A IL58906A (en) 1978-12-11 1979-12-10 Agent for the therapy of immunocomplex diseases

Country Status (8)

Country Link
US (1) US4479934A (en)
EP (1) EP0012305B1 (en)
JP (1) JPS5581817A (en)
AT (1) ATE2049T1 (en)
CA (1) CA1135185A (en)
DE (2) DE2853453A1 (en)
IL (1) IL58906A (en)
NO (1) NO794019L (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189014A (en) * 1979-12-03 1993-02-23 Cowan Jr Fred M Method of treating cellular Fc receptor mediated hypersensitivity immune disorders
FR2556219B1 (en) * 1983-12-07 1987-06-26 Merieux Inst NEW IMMUNOMODULATOR DRUG BASED ON HUMAN IGG FC FRAGMENTS
JPH0643343B2 (en) * 1984-12-28 1994-06-08 株式会社ミドリ十字 Immunomodulator
US4751181A (en) * 1984-12-31 1988-06-14 Duke University Methods and compositions useful in the diagnosis and treatment of autoimmune diseases
US4814433A (en) * 1987-09-16 1989-03-21 Miles Inc. Method for obtaining a papain-free antibody fragment preparation
US5422258A (en) * 1987-12-31 1995-06-06 Tanox Biosystems, Inc. Methods for producing high affinity anti-human IgE-monoclonal antibodies which binds to IgE on IgEabearing B cells but not basophils
US5449760A (en) * 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
US5691447A (en) * 1995-03-24 1997-11-25 Tanox Biosystems, Inc. GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
US7425331B2 (en) * 2002-04-10 2008-09-16 Protalex, Inc. Protein A methods of use
US7211258B2 (en) * 2002-04-10 2007-05-01 Protalex, Inc. Protein A compositions and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH392780A (en) * 1961-12-07 1965-05-31 Schweiz Rotes Kreuz Process for the production of intravenously applicable antibody preparations of human origin
US3466368A (en) * 1967-06-02 1969-09-09 Us Health Education & Welfare Cleavage of human gamma globulin by means of cyanogen bromide
GB1508132A (en) * 1974-05-20 1978-04-19 Technicon Instr Analysis of biological fluids
FR2279419A1 (en) * 1974-07-25 1976-02-20 Merieux Inst Aggregate-free immunoglobulin prepns. - obtained by treatment with complement Clq factor or rheumatic factor
DE2658334C3 (en) * 1976-12-23 1987-05-07 Behringwerke Ag, 3550 Marburg Process for the preparation of immunoglobulin preparations with reduced complement activity and a medicament containing them
DE2846412A1 (en) * 1978-10-25 1980-05-08 Behringwerke Ag AGENT FOR TREATING ALLERGIC REACTIONS

Also Published As

Publication number Publication date
EP0012305A1 (en) 1980-06-25
EP0012305B1 (en) 1982-12-22
DE2853453C2 (en) 1987-11-19
US4479934A (en) 1984-10-30
DE2853453A1 (en) 1980-06-19
CA1135185A (en) 1982-11-09
IL58906A0 (en) 1980-03-31
DE2964386D1 (en) 1983-01-27
ATE2049T1 (en) 1983-01-15
NO794019L (en) 1980-06-12
JPS5581817A (en) 1980-06-20

Similar Documents

Publication Publication Date Title
GB2110932A (en) Method and composition for treating acne
SE7714165L (en) DOCUMENT AND PROCEDURE FOR ITS TREATMENT
IE811431L (en) Pyrazinyl oxadiazoles
ES8403623A1 (en) PROCEDURE FOR THE DETERMINATION OF DIRECT AND TOTAL BILIRRUBINE IN BODY LIQUIDS.
IL58906A (en) Agent for the therapy of immunocomplex diseases
PT91953A (en) PROCESS FOR THE PREPARATION OF ANTIGEN SOLUTIONS CONTAINING ZINC HYDROXIDE OR IRON HYDROXIDE AS AN AUXILIARY AGENT
NL189799C (en) SEALED HOLDER INCLUDING, IN STERILE CIRCUMSTANCES, A FREEZE-DRIED PROTEIN CONTAINING METHOD AND METHOD FOR MANUFACTURING THE SAME
PL220416A2 (en)
GB2124487B (en) Agent for the treatment of wounds
FI853389A0 (en) TUMOERLAEKEMEDEL OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
DE3173396D1 (en) Tridecapeptide, process for its preparation and its use
DK376082A (en) INSECTICIDAL
NO792383L (en) CORRUGED BODY.
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
FI822616A7 (en) Labeled, immunologically active substance.
SE8104538L (en) 1-chloro-1-P METOXIBENSOYLFORMALDOXIM-N-methylcarbamate
IL61014A0 (en) Manufacture of 4-amino-5-chloro-1-phenylpyridaz-6-one
FR2479220B1 (en)
KR830005867A (en) Method of producing human prolactin
JPS527698A (en) Evacation guiding system
NL7703051A (en) COMPOSITE BODY AND METHOD FOR ITS MANUFACTURE.
IL57838A (en) Process for the preparation of o-methyl-n-cyclohexyl-2,5-dimethyl-furan-3-hydroxamic acid,n-cyclohexyl-n-methoxyacetoacetamide employed as intermediate therein and its preparation
NL7904054A (en) YARN AND METHODS FOR ITS MANUFACTURE AND USE.
SU1124506A1 (en) Working environment for electric-erosion treatment
SU1169215A1 (en) Preparation for treating animal dyspepsia